AdvertisementSupported byBusiness BriefingBy The Associated PressStepping into the furor over eye-popping price spikes for old generic medicines, a maker of compounded drugs will begin selling $1 doses of Daraprim, whose price recently was increased to $750 per pill by Turing Pharmaceuticals. Imprimis Pharmaceuticals, which mixes approved drug ingredients to fill individual patient prescriptions, said on Thursday it would supply capsules containing Daraprim’s active ingredients, pyrimethamine and leucovorin, for $99 for a 100-capsule bottle. “We are looking at all of these cases where the sole-source generic companies are jacking the price way up,” said Imprimis’s chief, Mark L. Baum. Advertisement